Evaluation of growth hormone assays using ratio plots

Clinical Chemistry

Volumn 44, Issue 5, 1998, Pages 1032-1038

  Andersen, Marianne ^a   Petersen, Per Hyltoft ^a   Blaabjerg, Ole ^a   Hangaard, Jørgen ^a   Hagen, Claus ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; PYRIDOSTIGMINE;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GROWTH HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN;

ADOLESCENT; ADULT; DATA INTERPRETATION, STATISTICAL; FLUOROIMMUNOASSAY; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; IMMUNORADIOMETRIC ASSAY; MIDDLE AGED; PYRIDOSTIGMINE BROMIDE; REAGENT KITS, DIAGNOSTIC;

EID: 0031900915     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 1991;12:424-49.
2. Baumann G, Stolar MW. Molecular forms of human growth hormone secreted in vivo: nonspecificity of secretory stimuli. J Clin Endocrinol Metab 1986;62:789-90.
3. Baumann G, Stolar MW, Amburn K. Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state. J Clin Endocrinol Metab 1985;60:1216-20.
4. Jansson C, Boguszewski CL, Rosberg S, Carlsson L, Albertsson-Wikland K. Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem 1997;43:950-6.
5. Andersen M, Hansen TB, Støving RK, Bertelsen J, Hangaard J, Petersen PH, et al. The pyridostigmine-growth-hormone-releasing-hormone test in adults. The reference interval and a comparison with the insulin tolerance test. Endocrinol and Metab 1996;3: 197-206.
6. Wyatt DT. Ad Hoc Committee for Standardization of Growth Hormone Assays [Letter and comment]. J Clin Endocrinol Metab 1995;80:3389-90.
7. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
8. Petersen PH, Stöckl D, Blaabjerg O, Pedsersen B, Birkemose E, Thienpont, L, et al. Graphical interpretation of analytical data from comparison of a field method with a reference method by use of difference plots. Clin Chem 1997;43:2039-46.
9. Dahler-Eriksen BE, Lassen JF, Petersen PH, Lund ED, Lauritzen T, Brandslund I. Evaluation of a near patient test for C-reactive protein while used in daily routine in primary health care by use of difference plots. Clin Chem 1997;43:2064-75.
10. Geary RC. The frequency distribution of the quantity of two normal values. J Roy Statist Soc 1930:442-6.
11. Hinkley DV. On the ratio of two correlated normal random variables. Clin Chem 1969;43:2039-46.
12. Stockl D, Baadenhuijsen H, Fraser CG, Libeer JC, Petersen PH, Ricos C. Desirable routine analytical goals for quantities assayed in serum. Discussion paper from the members of the external quality assessment (EQA) Working Group A on analytical goals in laboratory medicine. Eur J Clin Chem Clin Biochem 1995;33:157-69.
13. Fraser CG, Petersen PH, Ricos C, Haeckel R. Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry. Eur J Clin Chem Clin Biochem 1992;30:311-7.
14. Cotlove E, Harris EK, Williams GZ. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. Part 3. Physiological and medical implications. Clin Chem 1970;16:1028-32.
15. Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 1991;72:374-81.
16. Massa G. Bouillon R, Vanderschueren Lodeweyckx M. Serum growth hormone (GH)-binding protein and insulin-like growth factor-l levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol. J Clin Endocrinol Metab 1992;75:1298-1302.
17. Jan T, Shaw MA, Baumann G. Effects of growth hormone-binding proteins on serum growth hormone measurements. J Clin Endocrinol Metab 1991;72:387-91.
18. Mannor DA, Winer LM, Shaw MA, Baumann G. Plasma growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action. J Clin Endocrinol Metab 1991;73:30-4.
19. Veldhuis JD, Johnson ML, Faunt LM, Mercado M, Baumann G. Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications. J Clin Invest 1993;91:629-41.
20. Banfi G, Marinelli M, Pontillo M, Bonini P. Standardization with synthetic 22-kDa monomer human growth hormone reduces dis crepancies between two monoclonal immunoradiometric assay kits. Clin Chem 1992;38:2107-10.
21. WHO expert committee on biological standardization. WHO technical series [Abstract]. 1995;855:19-20.
22. Albertsson-Wikland K, Jansson C, Rosberg S, Novamo A. Time-resolved immunofluorometric assay of human growth hormone. Clin Chem 1993;39:1620-5.
23. Barth JH, Smith JH, Clarkson P. Wide diversity in measurements of growth hormone after stimulation tests in short children are due to assay variability. Ann Clin Biochem 1995;32:369-72.
24. Seth J, Ellis AR, Sturgeon CM. United Kingdom National External Quality Assessment Schemes for peptide hormones and related substances. Annual Review 1995:19-22.
25. Rahim A, Toogood AA, Shalet SM. The assessment of growth hormone status in normal young adult males using a variety of provocative agents. Clin Endocrinol 1996;45:557-62.